ステージIまたはステージIIの前立腺癌患者における埋め込み放射線療法およびホルモン療法後のPSA値と生検サンプル

基本情報

NCT ID: NCT00898326
ステータス: 完了
試験のフェーズ: -
試験タイプ: 観察
目標被験者数: 198
治験依頼者名: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

概要

RATIONALE: Studying samples of blood and tissue from patients with prostate cancer after receiving implant radiation therapy and luteinizing hormone-releasing hormone agonist may help doctors identify biomarkers related to cancer and help doctors predict how patients will respond to treatment. PURPOSE: This laboratory study is looking at PSA levels and biopsy samples after undergoing implant radiation therapy and luteinizing hormone-releasing hormone agonist therapy in patients with stage I or stage II prostate cancer.

対象疾患

Prostate Cancer

介入

biopsy(OTHER)

依頼者（Sponsor）

Jikei University School Of Medicine(OTHER)

Translational Research Center For Medical Innovation, Kobe, Hyogo, Japan(OTHER)

実施施設 (2)

Jikei University School of Medicine Hospital

Tokyo, Japan

日本大学医学部徳沢診療所

Tokyo, Japan